大湖水殖股份有限公司 制度管理制度 文号 DHGF-1J-HB-001 关联父项文号（如有） - 版次 A.1 管理部门 综合办公室 发文日期 2024-12-31 实施日期 2025-1-1 历次修改记载 序号 时间 修改内容 1 2024-12-31 首次发布 第一章 总则 第一条 目的及适用范围 （一）为进一步规范和加强大湖水殖股份有限公司（以下简称"公司"）制 度管理工作，根据公司章程及有关规定，结合公司实际情况，制定本制度。 （三）全面性原则：制度体系的内容范围应对管理业务进行全覆盖；制度体 系要注意系统性和协调性，要与管理流程协调和匹配，避免各项制度之间冲突、 交叉和遗漏。 （四）规范性原则：制度应当结构严谨，条理清楚，用语准确，文字简明。 第二章 部门职责 第四条 归口管理部门 董事会秘书办公室是公司一阶制度归口管理部门，综合办公室是公司二阶制 度归口管理部门，负责： （一）对公司制度的规范性进行审查； （二）本制度适用于公司、子公司及其他分支机构。 第二条 制度定义 本办法所称的"制度"是指公司、子公司及其他分支机构以及各部门按照规 定程序制定的各类规范经营管理行为的、具有长期普遍约束力的规范 ...

大湖水殖股份有限公司 信息披露管理制度 文号 DHGF-1J-HB-007 关联父项文号（如 有） - 版次 A.1 管理部门 董事会秘书办公室 发文日期 2024-12-31 实施日期 2025-01-01 历次修改记载 序号 时间 修改内容 1 2021-03-26 首次发布 2 2024-12-31 修订 第一章 总则 第一条 为了加强大湖水殖股份有限公司（以下简称"公司"）的信息披露管 理工作，确保正确履行信息披露义务，保护公司、股东、债权人及其他利益相关 人的合法权益，根据《中华人民共和国证券法》《中华人民共和国公司法》《上海 证券交易所股票上市规则》（以下简称"上市规则"）《上市公司信息披露管理办法》 《上海证券交易所上市公司自律监管指引第 2 号——信息披露事务管理》及公司 章程的规定，结合本公司实际情况，制定本制度。 第二条 本制度中的"信息"是指所有对公司证券及其衍生品种交易价格可能 产生重大影响的信息以及证券监管部门要求披露的信息；本制度所称"披露"是指 在规定的时间内、在规定的媒体上、以规定的方式向社会公众公布前述的信息， 并送达证券监管部门和上海证券交易所。 第三条 信息披露的基本原则 ...

大湖水殖股份有限公司 合同管理制度 文号 DHGF-1J-HB-005 关联父项文号（如有） - 版次 A.1 管理部门 法律合规部 发文日期 2024-12-31 实施日期 2025-01-01 历次修改记载 序号 时间 修改内容 1 2024-12-31 首次发布 第一章 总则 第一条 目的及适用范围 为加强大湖水殖股份有限公司（以下简称"公司"）合同管理工作，依法实 施签订、履行、变更和解除合同，预防和及时解决合同纠纷，维护公司的合法权 益，根据《中华人民共和国民法典》及其他相关法律法规的规定，特制订本制度。 本管理制度适用于公司和分公司，全资及控股子公司参照执行，子公司如确有必 要，可以在本制度原则下制定符合各自管理实际的合同管理办法。 第二条 概念范围 （一）本制度所称的合同是指公司生产、经营过程中与民事主体（其他法人、 非法人组织及自然人）之间，签订的设立、变更、终止民事法律关系的协议，包 括但不限于合同、协议、约定书、备忘录、意向书和其他具有合同性质的书面形 式文件。 （二）本制度所称的合同管理是对各类合同洽谈、订立、审批、履行、纠纷 处理以及档案管理等进行的管理活动。 第三条 订立原则 （一） ...

证券代码：600257 证券简称：大湖股份 公告编号：2024-033 大湖水殖股份有限公司 关于控股股东拟以专项贷款和 自有资金增持公司股份计划的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带责任。 重要内容提示： ●大湖水殖股份有限公司（以下简称"公司"）控股股东西藏泓 杉科技发展有限公司（以下简称"西藏泓杉"）拟计划自本公告披露 之日起 12 个月，通过上海证券交易所交易系统以集中竞价方式增持 公司股份，累计增持金额不低于人民币 7,500 万元（含），不超过人 民币 1.5 亿元（含），增持资金来源为自有资金和专项贷款。 ●本次增持计划不触及要约收购，不会导致公司控股股东及实际 控制人发生变化。 本次增持行为的主体为西藏泓杉，是公司的控股股东。 （二）增持主体已持有股份的数量及占公司总股本的比例 本次增持计划实施之前，西藏泓杉持有公司股票 104,631,211 股， 占公司总股本的 21.74%。 （三）本次公告前 12 个月内增持主体增持情况 西藏泓杉在拟计划增持的前 12 个月内，不存在通过上海证券交 易 ...

稽核情况告知书的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性 承担个别及连带责任。 证券代码：600257 证券简称：大湖股份 公告编号：2024-032 大湖水殖股份有限公司 关于子公司收到无锡市医疗保障基金管理中心 本次稽核事项不会影响公司子公司无锡国济康复医院的正常运 营。 三、公司拟采取的应对措施 公司控股子公司无锡国济康复医院将严格按照无锡医疗保障中 心关于入院指征、诊疗服务、收费结算等相关的要求进行整改，保 障医院的依法合规运营。 特此公告。 大湖水殖股份有限公司 一、本次稽核情况概述 大湖水殖股份有限公司（以下简称"公司"）控股子公司无锡 市国济康复医院有限公司（以下简称"无锡国济康复医院"）于 2024 年 10 月 28 日收到无锡市医疗保障基金管理中心（以下简称 "无锡医疗保障中心"）的稽核情况告知书（锡医管稽告字【2024】 0619 号）。无锡医疗保障中心在国家医保局、江苏省医保局的指导 下，进驻无锡市下辖所有县区，对 100 多家定点医药机构开展全面 专项监督检查，在监督检查当中发现无锡国济康复医院存在超标 ...

Financial Performance - The company's operating revenue for Q3 2024 was ¥267,721,004.17, a decrease of 5.31% compared to the same period last year[2] - The net profit attributable to shareholders was -¥7,639,839.04, with a year-to-date net profit of -¥21,422,233.02[2] - The basic earnings per share for the quarter was -¥0.0159, reflecting a decrease of ¥0.0440 compared to the previous year[2] - Total operating revenue for the first three quarters of 2024 was CNY 764,848,062.43, a decrease of 12.4% compared to CNY 872,830,730.71 in the same period of 2023[16] - Net profit for the third quarter of 2024 was CNY -7,523,087.49, compared to a net profit of CNY 20,108,652.59 in the same quarter of 2023[17] - The company reported a gross profit margin of approximately 2.1% for the first three quarters of 2024, compared to 2.8% in the same period of 2023[16] - Total comprehensive income attributable to the parent company was -21,335,901.75 CNY, compared to 6,380,188.11 CNY in the same period last year[18] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,941,661,837.91, down 6.54% from the end of the previous year[4] - The company's total assets decreased to CNY 1,941,661,837.91 in Q3 2024 from CNY 2,077,597,869.84 in Q3 2023, a decline of approximately 6.5%[15] - Current liabilities totaled CNY 415,684,483.18 in Q3 2024, down 18.3% from CNY 508,819,963.53 in Q3 2023[15] - The company’s total liabilities decreased to CNY 929,899,948.30 in Q3 2024 from CNY 1,059,830,852.29 in Q3 2023, a decline of 12.3%[15] - Long-term borrowings decreased to CNY 110,500,000.00 in Q3 2024 from CNY 139,200,000.00 in Q3 2023, a reduction of 20.6%[15] Cash Flow - The company reported a net cash flow from operating activities of ¥35,283,466.90, down 17.63% year-to-date[2] - Cash inflow from operating activities for the first three quarters of 2024 was 803,550,552.39 CNY, down 15.5% from 950,391,117.69 CNY in 2023[20] - Net cash flow from operating activities was 35,283,466.90 CNY, a decrease of 17.5% compared to 42,837,061.53 CNY in the previous year[22] - Cash inflow from investment activities increased significantly to 94,749,375.56 CNY, compared to 27,306,994.00 CNY in the same period last year[22] - Net cash flow from investment activities was -25,633,296.75 CNY, contrasting with a positive 3,750,380.87 CNY in 2023[22] - Cash inflow from financing activities was 190,000,000.00 CNY, down from 312,200,000.00 CNY in the previous year[22] - Net cash flow from financing activities was -127,736,893.32 CNY, compared to a positive 10,525,553.59 CNY in the same period last year[22] - The ending balance of cash and cash equivalents was 218,071,257.60 CNY, down from 288,125,736.12 CNY at the end of the previous year[22] Shareholder Information - The total number of common shareholders at the end of the reporting period was 60,825[9] - The largest shareholder, Tibet Hongshan Technology Development Co., Ltd., holds 104,631,211 shares, accounting for 21.74% of the total shares[9] - The company has no significant changes in the shareholding structure of the top ten shareholders compared to the previous period[10] Operational Insights - Accounts receivable increased by 48.60% due to the concentrated sales period of the crayfish series products[7] - Contract liabilities rose by 42.16% as payments for crab card sales were received but goods had not yet been picked up by customers[7] - The company experienced a decrease in accounts payable by 42.28% due to reduced inventory purchases following a decline in sales revenue[7] - Inventory stood at 431,428,252.45 RMB, slightly down from 455,021,341.59 RMB, indicating a decrease of about 5.2%[12] - The total current assets decreased to 868,468,229.47 RMB from 954,499,301.96 RMB, a decline of approximately 9%[12] - The company reported a total of 34,123,238.36 RMB in trading financial assets, an increase from 20,000,000.00 RMB, marking a growth of 70.6%[12] - The company has not disclosed any new product developments or market expansion strategies in the current report[11] - There are no significant reminders or additional important information regarding the company's operational situation during the reporting period[11] Research and Development - Research and development expenses for the first three quarters of 2024 were CNY 407,016.22, significantly lower than CNY 840,711.32 in 2023, a decrease of 51.6%[16] Accounting Standards - The company did not apply new accounting standards for the current year[23]

证券代码：600257 证券简称：大湖股份 公告编号：2024-031 大湖水殖股份有限公司 关于为子公司提供担保的进展公告 ●在本次披露的 2024 年年度预计担保额度范围内的担保进展中， 新签担保协议不涉及反担保。 ●截止本公告披露日，公司无对外担保逾期情况。 一、年度担保预计情况概述 公司分别于 2024 年 1 月 19 日、2024 年 2 月 5 日召开第九届董 事会第七次会议、2024 年第一次临时股东大会审议通过了《关于 2024 年度公司为子公司提供担保额度预计的议案》，同意公司预计 2024 年度为公司合并报表范围内子公司提供担保的总额度为不超过 人民币 26,500.00 万元，担保方式包括但不限于信用担保、抵押担 保、质押担保（含一般保证、连带责任保证）等，该担保额度包括 新增担保及原有担保的展期或者续保。具体内容详见公司于 2024 年 1 月 20 日在上海证券交易所网站披露的公告（公告编号：2024- 002）。 二、担保进展情况 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性 承担个别及连带责任。 重要内容提 ...

证券代码：600257 证券简称：大湖股份 公告编号：2024-030 大湖水殖股份有限公司 关于参加湖南辖区 2024 年度 投资者网上集体接待日活动的公告 本公司及董事会全体成员保证本公告内容不存在任何虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性 和完整性承担个别及连带责任。 为进一步加强与投资者的互动交流，使广大投资者能更深入 全面地了解大湖水殖股份有限公司（以下简称"公司"）情况，公 司将参加由湖南证监局、湖南省上市公司协会和深圳市全景网络 有限公司联合举办的"湖南辖区 2024 年度投资者网上集体接待 日"活动，现将有关事项公告如下： 本次活动将采用"网络远程"的方式举行，投资者可登录"全 景路演"网站（https://rs.p5w.net），或关注微信公众号：全景 财经，或下载全景路演 APP，参与本次互动交流，活动时间为 2024 年 10 月 10 日（星期四）下午 14:00 至 17:00。届时公司高管等 相关人员将在线就公司 2023 年至 2024 年半年度业绩、公司治理、 发展战略、经营状况、融资计划、股权激励和可持续发展等投资 者关心的问题，与投资者进行沟通与交流 ...

证券代码：600257 证券简称：大湖股份 公告编号：2024-028 大湖水殖股份有限公司 第九届监事会第九次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带责任。 （1）公司 2024 年半年度报告的编制和审计程序符合法律、法规、 公司章程和公司内部管理制度的各项规定。 （2）公司 2024 年半年度报告的内容和格式符合中国证监会和上 海证券交易所的各项规定，所包含的信息能从各个方面真实地反映出 公司 2024 年半年度报告的经营管理和财务状况等事项。 （3）在提出本意见之前，监事会没有发现参与 2024 年半年度报 告编制人员有违反保密规定的行为。 表决结果：同意 3 票，反对 0 票，弃权 0 票，该议案获得全体监 事全票表决通过。 具体内容详见上海证券交易所网站（http://www.sse.com.cn） 披露的《大湖水殖股份有限公司 2024 年半年度报告》。 二、审议通过了《关于2024年半年度计提资产减值准备的议案》 为真实、准确和公允地反映公司 2024 年半年度的财务状况以及 经营情况，基于 ...

Financial Performance - The company's operating revenue for the first half of 2024 was CNY 497,127,058.26, a decrease of 15.76% compared to CNY 590,099,510.55 in the same period last year[20] - The net profit attributable to shareholders for the first half of 2024 was a loss of CNY 13,782,393.98, which is a 23.55% increase in loss compared to a loss of CNY 11,155,304.90 in the previous year[20] - The net cash flow from operating activities was a negative CNY 104,152,373.58, representing a 50.22% increase in cash outflow compared to CNY 69,332,879.43 in the same period last year[20] - The basic earnings per share for the first half of 2024 was -CNY 0.0286, a decrease of 23.45% compared to -CNY 0.0232 in the same period last year[21] - The weighted average return on net assets was -1.586%, a decrease of 0.31 percentage points from -1.28% in the previous year[21] - The company reported a decrease in the net profit after deducting non-recurring gains and losses, with a figure of -CNY 16,760,401.07 compared to -CNY 16,946,448.14 in the previous year, reflecting a 1.10% improvement[20] Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,003,661,273.90, down 3.56% from CNY 2,077,597,869.84 at the end of the previous year[20] - The net assets attributable to shareholders decreased by 1.87% to CNY 859,816,044.18 from CNY 876,156,555.30 at the end of the previous year[20] - The total liabilities increased to CNY 778,078,458.63 in the first half of 2024 from CNY 712,397,586.01 in the same period of 2023, reflecting a growth of 9.23%[164] - The total equity decreased to CNY 996,662,653.48 in the first half of 2024 from CNY 1,014,409,505.97 in the same period of 2023, a decline of 1.73%[164] Revenue Breakdown - The company's revenue from aquatic products accounted for 48.48% of total revenue during the reporting period[29] - The white liquor business contributed 9.74% to the company's total revenue[30] - The rehabilitation and nursing medical business represented 39.42% of total revenue[33] Market and Industry Trends - The white liquor industry is undergoing structural adjustments, with policies promoting quality standards and production methods, enhancing the market for high-end products[44] - The demand for high-end white liquor is increasing, driven by consumer health awareness and rising disposable income, leading to a shift towards premium brands[47] - The Chinese rehabilitation medical market is expected to exceed 220 billion yuan by 2025, highlighting significant growth potential due to an aging population and increasing rehabilitation needs[51] Social Responsibility and Community Engagement - The company and its subsidiaries donated a total of 50,000 yuan to support rural revitalization and poverty alleviation projects as of June 30, 2024, with 30,000 yuan allocated to Yanglouping Village and 20,000 yuan for organic fertilizer in Wanrendong Village[95] - The company is actively participating in key projects related to rural revitalization as part of its social responsibility initiatives[95] Research and Development - The company has made significant progress in research and innovation, achieving awards for key technologies in freshwater fish processing and breeding[57] - Research and development expenses for the first half of 2024 were CNY 244,228.75, down 39.29% from CNY 402,439.14 in the first half of 2023[164] Future Outlook and Strategic Initiatives - The company is focusing on market expansion, targeting a 25% increase in market share within the next fiscal year[117] - The company aims to improve operational efficiency, targeting a 10% reduction in costs through process optimization[118] - Future outlook remains positive, with an expected overall growth rate of 15% in the upcoming quarters[117] Guarantees and Financial Commitments - The total guarantee amount (including guarantees for the company) is 458,378,579.8 RMB, which accounts for 52.32% of the company's net assets[128] - The total amount of guarantees includes 166,200,000.00 RMB for ongoing rental guarantees for two hospitals in Hangzhou[131] Cash Flow and Liquidity - The company reported a net decrease in cash and cash equivalents of -14,505,465.19 RMB for the first half of 2024, contrasting with an increase of 7,903,927.96 RMB in the same period of 2023[183] - The ending balance of cash and cash equivalents was 68,889,325.91 RMB, down from 55,269,335.29 RMB year-over-year, indicating a liquidity contraction[183]